News
Researchers from Lawrence Livermore National Laboratory (LLNL), in collaboration with other leading institutions, have ...
SEKISUI Diagnostics is a well-known provider of many rapid diagnostic solutions to the professional and home testing markets ...
A novel antiviral targeting the SARS-CoV-2 PLpro protease shows strong efficacy in a mouse model, preventing lung pathology and reducing brain dysfunction. The study provides proof-of-principle ...
Apr. 4, 2025 — New research shows how small shifts in the molecular makeup of a virus can profoundly alter its fate. These shifts could turn a deadly pathogen into ... Research Uncovers Hidden ...
and the inhibition of anti-SARS-CoV-2 antibody binding to M2 protein was demonstrated graphically in proportion to the increased concentration of M2 protein in the test tubes containing the SARS-CoV-2 ...
The department of home affairs and two entities it oversees have signed what home affairs minister Leon Schreiber said was a “groundbreaking agreement” with the SA Revenue Service (Sars) to ...
Strain-specific VE estimates were calculated using the test-negative design, controlling for potential cofounders. Separate analyses were performed for the monovalent Rotarix® vaccine (RV1, ...
Apr. 3, 2025 — Drug-carrying DNA aptamers can deliver a one-two punch to leukemia by precisely targeting the elusive cancer stem cells that seed cancer relapses, ...
Recent advances in transcriptomics research have uncovered heightened interferon (IFN) responses in neurodegenerative diseases including Alzheimer’s disease, primary tauopathy, Parkinson’s disease, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results